Literature DB >> 35661496

Symptomatic burned-out testicular seminoma: A case report.

Marchese Tiziana1, Botrugno Ivan1, Perrone Federico1, Serio Giovanni2, Marcello Spampinato1, William Sergi3.   

Abstract

INTRODUCTION AND IMPORTANCE: Burned-out testicular cancer is a rare phenomenon to be taken into account for differential diagnosis in males presenting with retroperitoneal lymphadenopathy. CASE
PRESENTATION: A 54-years-old male complaining of abdominal pain over the past several months was found on CT to have a large mass adjacent to the inferior vena cava, with the imaging features of a malignant lymphadenopathy. CLINICAL DISCUSSION: The hematologist who evaluated the case suggested a biopsy of the retroperitoneal mass: a seminoma was diagnosed on pathological examination. Then a testicular US revealed a focal peripheral hypoechoic region with no associated internal vascularization within the right testicle.
CONCLUSION: This case report highlights the need for routine scrotal examination in all men presenting with an abdominal mass in order to rule out the possibility of an intra-abdominal seminoma.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Burned-out tumor; Retroperitoneal adenopathy; Seminoma; Testicular cancer

Year:  2022        PMID: 35661496      PMCID: PMC9511695          DOI: 10.1016/j.ijscr.2022.107245

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Burned-out testicular tumor is the rare presentation of a metastatic germ cell tumor with an occult/regressed primary testicular lesion. It is uncommon, seen in approximately 10% of primary germ cell tumors, but this disease cannot be missed due to the serious impact on treatment [2]. We present a case of a patient with symptomatic retroperitoneal lymphadenopathy, who was subsequently found to have a primary lesion within the right testicle.

Case report

A 54-year-old male presented to the Emergency Department describing history of several months of vague abdominal pain. At the time of presentation, the patient denied fever, chills and night sweats or feeling fatigue or lethargy. A total-body CT scan showed a large retroperitoneal polycyclic mass adjacent to the inferior vena cava, with the radiological characteristics of a malignant lymphadenopathy (Fig. 1).
Fig. 1

Malignant retroperitoneal lymphadenopathy at CT scan.

Malignant retroperitoneal lymphadenopathy at CT scan. After hematological advice, that confirmed the need of a histological definition, the patient was admitted to our Division and he underwent a US-guided percutaneous core biopsy of the retroperitoneal mass. The hospital stay was uneventful and the patient was discharged the day after the procedure. The diagnosis of seminoma was made after pathological examination. Based on these findings, at the next control we performed testicular US evaluation: US demonstrated a small hypoechoic lesion at the periphery of the right testis, without evidence of increased internal vascularization.

Discussion

Testicular tumors are the most common malignancy in males between 15 and 44 years [3]. Primary testicular tumors are divided into non-germ cell and germ cell tumors. These last, more frequently identified, probably arise from the failure of maturation of normal gonocytes [4]. They are further divided into seminomas (more common), and non-seminomas (rarer, they include choriocarcinoma, embryonal cell carcinoma, yolk sac tumor, teratoma and mixed germ cell tumor). Germ cell tumors are not necessarily confined to the testicles: other sites include mediastinum and retroperitoneum. These tumors represent approximately 5–10% of all germ cell tumors, the most common being the mature teratoma [5]. Testicular cancer classically manifests as a painless palpable testicular mass and US is typically the imaging of choice for primary diagnosis. In 2–10% of germ cell tumors a metastatic disease is identified on imaging, without involvement of the testicles [5], [6]. A burned-out testicular tumor consists of a regressed primary testicular lesion with a metastatic focus of disease. This is thought to be due to the primary tumor outgrowing its blood supply resulting in its regression [7], [8]. A burned-out testicular tumor can have different US appearance, ranging from small areas of hypo- or hyper-echogenicity and/or focal calcification to a completely normal or diminutively-sized testis. This presentation, while rare overall, is more typically seen in choriocarcinoma and embryonal cell carcinoma; only a few case reports describe this phenomenon involving a seminoma [3]. Treatment of a burned-out testicular tumor requires orchiectomy with or without adjuvant chemotherapy and/or radiation [6]. It is therefore important to distinguish primary extragonadal germ cell tumors from burned-out testicular tumors, since treatments are different.

Conclusion

Burned-out testicular cancer is a rare phenomenon to be considered for differential diagnosis in young males presenting with retroperitoneal lymphadenopathy. It is imperative to differentiate these cases from primary extragonadal germ cell tumors that follow a different treatment regimen and typically manifest in other locations, such as mediastinum and retroperitoneum [5]. Both physical exam and US of the testicles are to be warranted in all young males to make the correct diagnosis.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Ethical approval

In our institute, the approval of the ethics committee for the retrospective analysis of a clinical case report is not required.

Sources of funding

None funding were used.

Guarantor

Spampinato Marcello.

Registration of research studies

The submitted case report is not a research study.

Provenance and peer review

Not commissioned, externally peer-reviewed.

CRediT authorship contribution statement

William Sergi: author of work and manuscript writing. Tiziana Marchese: co-author. Ivan Botrugno, Giovanni Serio: co-authors of discussion. Federico Perrone: data collection. Marcello Spampinato: supervisor.

Declaration of competing interest

The authors declare no conflict of interests.
  7 in total

Review 1.  Testicular germ cell tumor: a comprehensive review.

Authors:  Aalia Batool; Najmeh Karimi; Xiang-Nan Wu; Su-Ren Chen; Yi-Xun Liu
Journal:  Cell Mol Life Sci       Date:  2019-01-22       Impact factor: 9.261

2.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.

Authors:  Riaz A Agha; Thomas Franchi; Catrin Sohrabi; Ginimol Mathew; Ahmed Kerwan
Journal:  Int J Surg       Date:  2020-11-09       Impact factor: 6.071

3.  Retroperitoneal seminoma with 'burned out' phenomenon in the testis.

Authors:  Petros Perimenis; Anastasios Athanasopoulos; John Geraghty; Ru Macdonagh
Journal:  Int J Urol       Date:  2005-01       Impact factor: 3.369

4.  Testicular tumors: what radiologists need to know--differential diagnosis, staging, and management.

Authors:  Courtney Coursey Moreno; William C Small; Juan C Camacho; Viraj Master; Nima Kokabi; Melinda Lewis; Matthew Hartman; Pardeep K Mittal
Journal:  Radiographics       Date:  2015 Mar-Apr       Impact factor: 5.333

5.  'Burned-out' primary testicular cancer.

Authors:  Elodie Fabre; Hassan Jira; Vincent Izard; Sophie Ferlicot; Yacine Hammoudi; Christine Theodore; Mario Di Palma; Gerard Benoit; Stephane Droupy
Journal:  BJU Int       Date:  2004-07       Impact factor: 5.588

Review 6.  Testicular Seminoma and Its Mimics: From the Radiologic Pathology Archives.

Authors:  Jamie Marko; Darcy J Wolfman; Alex L Aubin; Isabell A Sesterhenn
Journal:  Radiographics       Date:  2017-06-02       Impact factor: 5.333

7.  Burned-Out Testicular Cancer: Really a Different History?

Authors:  Claudia Mosillo; Simone Scagnoli; Giulia Pomati; Salvatore Caponnetto; Maria Laura Mancini; Mario Bezzi; Enrico Cortesi; Alain Gelibter
Journal:  Case Rep Oncol       Date:  2017-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.